封面
市場調查報告書
商品編碼
1212707

市售的生物科技用分離設備的全球市場

Commercial Biotechnology Separation Systems

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 273 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市售的生物科技用分離設備的全球市場2030年將達到310億美元

在COVID-19後改變的商務環境中,2022年246億美元的市售的生物科技用分離設備的全球市場,從2022年2030年關於年複合成長率2.9%的速度成長,到2030年達到310億美元。本報告所分析之市場區隔之一的傳統年複合成長率將記錄2.7%,到分析期間結束時達到190億美元。考慮疫情後的復甦,現代領域今後8年的年複合成長率將修正為3.3%。

美國市場估算為67億美元,中國則將以年複合成長率4.8%增長

美國的市售的生物科技用分離設備市場在2022年估算為67億美元。作為世界第2大經濟大國的中國,在2022年~2030年年複合成長率預計將為4.8%,在2030年將達到60億美元的市場規模。其他熱門的地區市場有日本和加拿大,在2022年~2030年預計將各以1.6%和2.4%的速度成長。在歐洲市場中,德國將以年複合成長率2%成長。

調查對像企業範例

  • 3M Company
  • AB Sciex
  • Agilent Technologies, Inc.
  • Alfa Laval AB
  • Alfa Wassermann Separation Technologies LLC
  • Beckman Coulter Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Flottweg SE
  • Fluidigm Corporation
  • GE Healthcare
  • Hitachi High-Technologies Corp.
  • Illumina Inc.
  • Merck KGaA
  • Pall Corporation
  • PerkinElmer Inc.
  • ProMetic Life Sciences Inc.
  • Repligen Corporation
  • Sartorius Stedim Biotech SA
  • Shimadzu Scientific Instruments
  • Sysmex Partec GmbH
  • Thermo Fischer Scientific Inc.

目錄

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 主要企業
  • 市場趨勢與推動因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東
  • 非洲

第4章 競爭

簡介目錄
Product Code: MCP-7990

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Commercial Biotechnology Separation Systems Market to Reach $31 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Commercial Biotechnology Separation Systems estimated at US$24.6 Billion in the year 2022, is projected to reach a revised size of US$31 Billion by 2030, growing at aCAGR of 2.9% over the period 2022-2030. Conventional, one of the segments analyzed in the report, is projected to record 2.7% CAGR and reach US$19 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Modern segment is readjusted to a revised 3.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $6.7 Billion, While China is Forecast to Grow at 4.8% CAGR

The Commercial Biotechnology Separation Systems market in the U.S. is estimated at US$6.7 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$6 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.6% and 2.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2% CAGR.

Select Competitors (Total 46 Featured):

  • 3M Company
  • AB Sciex
  • Agilent Technologies, Inc.
  • Alfa Laval AB
  • Alfa Wassermann Separation Technologies LLC
  • Beckman Coulter Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Flottweg SE
  • Fluidigm Corporation
  • GE Healthcare
  • Hitachi High-Technologies Corp.
  • Illumina Inc.
  • Merck KGaA
  • Pall Corporation
  • PerkinElmer Inc.
  • ProMetic Life Sciences Inc.
  • Repligen Corporation
  • Sartorius Stedim Biotech SA
  • Shimadzu Scientific Instruments
  • Sysmex Partec GmbH
  • Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Separation Technologies Drive Biotechnology Industry
    • Recent Market Activity
    • Developed Markets Lead the Way while Emerging Markets Promise Growth
    • DNA Microarrays - Largest & Fastest Growing Segment
    • Liquid Chromatography - One of the Leading Biotechnology Separation Technologies
    • Factors Sustaining Market Growth
    • Factors Restraining Growth
    • Commercial Biotechnology Separation Systems - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
    • 3M (USA)
    • AB Sciex LLC (USA)
    • Agilent Technologies, Inc. (USA)
    • Alfa Laval AB (Sweden)
    • Alfa Wassermann Separation Technologies, LLC (USA)
    • Beckman Coulter, Inc. (USA)
    • Becton, Dickinson and Company (USA)
    • Bio-Rad Laboratories, Inc. (USA)
    • Flottweg SE (Germany)
    • Fluidigm Corporation (USA)
    • GE Healthcare (USA)
    • Groupe Novasep (France)
    • Hitachi High-Technologies Corp. (Japan)
    • Illumina, Inc. (USA)
    • Merck KGaA (Germany)
    • Pall Corporation (USA)
    • PerkinElmer, Inc. (USA)
    • ProMetic Life Sciences, Inc. (Canada)
    • Repligen Corporation (USA)
    • Sartorius Stedim Biotech SA (France)
    • SEPMAG (Spain)
    • Shimadzu Scientific Instruments (USA)
    • Sysmex Partec GmbH (Germany)
    • Thermo Fisher Scientific, Inc. (USA)
  • 3. MARKET TRENDS & DRIVERS
    • Bioseparation Systems - Invaluable Tools in Biopharmaceutical Manufacturing
    • A Peek into Biopharmaceutical Manufacturing
    • Downstream Processing of Biosynthetic Products - An Overview
    • Surging Biopharmaceutical Market Spurs Demand for Bioseparation Systems
    • New Biologic License Application (BLA) Approvals: 2017
    • New Biologic License Application (BLA) Approvals: 2016
    • New Biologic License Application (BLA) Approval: 2015
    • Evolving Biopharmaceutical Industry Emphasizes on Novel Technologies
    • Increasing Emphasis on Personalized Medicine Drives Market Growth
    • Rise in Healthcare Spending Bodes Well for Market Growth
    • Aging Population Drives Biotechnology Separation Systems Market
    • Global Aging Population Statistics - Opportunity Indicators
    • Increasing Incidence of Cancer Drives Biotechnology Separation Systems Market
    • Increasing Competition Spurs Renewed Focus on Efficiencies
    • Growing Orphan Drugs Market Draws Attention towards Manufacturing Flexibility
    • Downstream Processing - A Major Trend among Biopharmaceutical Manufacturers
    • Upstream and Downstream Mismatch Turns Focus towards Innovative Technologies
    • Protein Separation in Biopharmaceutical Space Assumes Greater Significance
    • Growing Market for Monoclonal Antibodies - A Key Review of Current Status and Future Prospects
    • Approved Monoclonal Antibodies: 2014-2017
    • An Insight into Bioseparation of mAbs
    • Market Potential for Biosimilars - A Case for Substantial Demand for Separation Technologies
    • US Approved Biosimilars as of December 2017
    • Europe Approved Biosimilars as of December 2017
    • Patent Expiries Create Opportunities for Biosimilar Manufacturers
    • Patent Expiries of Major Biologics in the US and Europe
    • Huge Biopharmaceutical Pipeline - A Clear Indicator of Future Prospects
    • Disposables to Infuse Cost Effectiveness in Biopharmaceutical Production
    • Single-Use Products Gain Significant Attention
    • Market Prospects for Single-Use Disposable Technologies
    • Select Commercial Disposable/Single-Use Technologies by Process Technique
    • Innovations in Single-use Systems
    • Modular Bioprocessing - An Emerging Trend
    • Leachables and Extractables Trounce Enthusiasm around Disposables
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 3: World 18-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Conventional by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Conventional by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 6: World 18-Year Perspective for Conventional by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Modern by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Modern by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 9: World 18-Year Perspective for Modern by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 12: World 18-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Food & Cosmetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Food & Cosmetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 15: World 18-Year Perspective for Food & Cosmetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 18: World 18-Year Perspective for Agriculture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 21: World 18-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 22: World Commercial Biotechnology Separation Systems Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 25: USA 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 28: USA 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 31: Canada 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 34: Canada 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • JAPAN
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 37: Japan 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 40: Japan 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • CHINA
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 43: China 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 46: China 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • EUROPE
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 49: Europe 18-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2023 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 52: Europe 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 55: Europe 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • FRANCE
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 58: France 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 61: France 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • GERMANY
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 64: Germany 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 67: Germany 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 70: Italy 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 73: Italy 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • UNITED KINGDOM
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 76: UK 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 79: UK 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 82: Spain 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 85: Spain 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 88: Russia 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 91: Russia 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 94: Rest of Europe 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 97: Rest of Europe 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • ASIA-PACIFIC
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 100: Asia-Pacific 18-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2023 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 103: Asia-Pacific 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 106: Asia-Pacific 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • AUSTRALIA
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 109: Australia 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 112: Australia 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • INDIA
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 115: India 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 118: India 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 121: South Korea 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 124: South Korea 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • LATIN AMERICA
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 133: Latin America 18-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2023 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 136: Latin America 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 139: Latin America 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 142: Argentina 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 145: Argentina 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 148: Brazil 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 151: Brazil 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 154: Mexico 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 157: Mexico 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 160: Rest of Latin America 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 163: Rest of Latin America 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • MIDDLE EAST
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 166: Middle East 18-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2023 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 169: Middle East 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 172: Middle East 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 175: Iran 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 178: Iran 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 181: Israel 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 184: Israel 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 187: Saudi Arabia 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 190: Saudi Arabia 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 193: UAE 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 196: UAE 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 199: Rest of Middle East 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 202: Rest of Middle East 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030
  • AFRICA
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 205: Africa 18-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2012, 2023 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 208: Africa 18-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2012, 2023 & 2030

IV. COMPETITION